Home › Trial NCT03127449
AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
- Trial IDNCT03127449
- StatusTerminated
- PhaseN/A
- Study typeInterventional
- SponsorAllist Pharmaceuticals, Inc.
- Enrollment116
- Start date2017-06-01
- ConditionsAdvanced NSCLC
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.